Candidiasis
66
1
1
51
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
12 trials with published results (18%)
Research Maturity
51 completed trials (77% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.1%
8 terminated out of 66 trials
86.4%
-0.1% vs benchmark
41%
27 trials in Phase 3/4
24%
12 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (66)
PTX3-targeted Antifungal Prophylaxis
Staging Candidiasis in ICU Patients
Fluconazole Versus Micafungin in Neonates With Candidiasis
Vaginal Ecosystem and Network in the United States Study
Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration
Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients
Bioavailability of Flucanazole
Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine
Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections
Early Diagnosis of Candidiasis in Premature Infants
Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight